Source: Lauri Patterson/Getty Images
• Peanut allergy sufferers are one step closer to a treatment after an FDA committee voted to approve Palforzia. A form of oral immunotherapy, the powder can desensitize the immune system to peanuts, reducing allergic reactions. This could be the first FDA-approved treatment for peanut allergies. Read More
• An inexpensive pill consisting of low doses of three blood pressure drugs and a cholesterol drug has recently been tested in the U.S., successfully lowering participant blood pressure and LDL. Similar drugs have been effective in treating conditions leading to heart attacks and strokes in other countries and may be a valuable treatment option for those with limited access to medical care in the U.S. Read More
• A recent study found that nearly 20 percent of surgeons in the U.S. predict they will need to retire early due to the physical strains of laparoscopic surgery. While close to 80 percent of those surveyed have experienced some sort of muscular or back pain, 13 percent have also required a consult with another healthcare professional for their injuries. Read More
• A new machine learning model can better predict heart failure in patients with type 2 diabetes. Researchers have been able to generate a risk score for patients based on the top 10 predictors of future heart failure. By integrating this risk score into bedside practice or EHR systems, it may help identify patients who would benefit from therapeutic interventions. Read More
Each Friday, Signor Goat reports the latest from the week in health care. Check back next Friday for your dose of our little medical corner of health care news. Brought to you by pMD, innovators in charge capture, secure messaging, clinical communication, and care navigation software.